Trial Search Results

Biomarkers for the Detection of Lymphatic Insufficiency

Acquired lymphedema is a disease that causes chronic swelling of the limb(s). It is frequently under-recognized or misdiagnosed. This study is designed to lead to the development of an accurate, noninvasive, blood test to allow testing for lymphedema.

Stanford is currently accepting patients for this trial.

Lead Sponsor:

Stanford University

Collaborator: Memorial Sloan Kettering Cancer Center

Stanford Investigator(s):

Intervention(s):

  • Procedure: tissue sampling

Eligibility


Inclusion Criteria:

For lymphedema participants:

history of acquired lymphedema of at least 6 months' duration.

For non-lymphedema participants with risk factors:

have undergone lymph node dissection and/or radiation therapy with no evidence of
lymphedema

Control participants: no evidence of lymphedema, no lymph node dissection, no radiation
therapy

Exclusion Criteria:

active cancer, infection or bleeding tendency

Ages Eligible for Study

18 Years - N/A

Genders Eligible for Study

All

Now accepting new patients

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Recruiting